Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease
We are delighted to announce our upcoming webinar on Thursday, September 14, 10:00 am ET. From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease. Alzheimer’s disease research has taken center stage in the world of drug discovery and clinical development. The convergence of causal AI, supercomputing power, and multi-omic […]
Realizing AI’s Potential in Drug Discovery: Join our CEO, Colin Hill on the Top of Mind for Life Sciences Summit 2023
We are excited to announce that Aitia will be participating in the highly anticipated Top of Mind for Life Sciences Summit 2023 conference. Our CEO, Colin Hill, will be a featured speaker on an insightful panel discussion entitled “Realizing AI’s Potential in Drug Discovery” moderated by Rob Hartman, Senior Director from UPMC Enterprises. During the […]
Colin Hill Keynote at Servier Paris-Saclay R&D Institute in France
On July 20th, we had the privilege to visit the cutting-edge Servier Paris-Saclay R&D Institute in France, where our CEO, Colin Hill delivered a keynote titled: “Why AI and Digital Twins will Drive the Discovery and Development of the Next Generation of Breakthrough Drugs“. The open conference was a remarkable display of Servier’s dedication to foster a collaborative […]
Alzheimer’s Disease Mechanistic Pathways Discovered through Aitia’s Digital Twins and in silico Experiments in Causal AI to be Presented at AAIC 2023
We are delighted to announce that Aitia will be at the upcoming Alzheimer’s Association International Conference (AAIC) being held from July 16-20 in Amsterdam, Netherlands. We will be presenting a poster focused on identification of gene pathways with direct causal relationships to Alzheimer’s Disease (AD) through Gemini Digital Twins of AD patients, based on Bayesian […]
Join our CEO, Colin Hill on the Aspen Ideas: Health Panel
We are thrilled to announce that Aitia will be participating in the highly anticipated Aspen Ideas: Health conference. Our CEO, Colin Hill, will be taking the stage on a thought-provoking panel titled “Open to Debate: Is the FDA too Cautious?” alongside distinguished panelist Peter Lurie, President and Executive Director of the Center for Science in […]
Join Aitia at the Drug Discovery Europe & Neuroscience Drug Development Europe 2023 Conference in Berlin
We are thrilled to announce that our CBO, Joe Donahue will be taking the stage at the Drug Discovery Europe & Neuroscience Drug Development Europe 2023 Conference in Berlin, Germany. Session title: Digital Twins Unlock the Biological Complexity of Human Disease and Will Drive the Next Wave of Breakthrough Drugs Digital Twins are computational representations of […]
Join Aitia at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine – AIPM 2023
Join us at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine on June 5, sponsored by Pfizer Inc., the Roux Institute at Northeastern University, and the American Statistical Association (ASA). At Aitia, we are excited to present a session entitled “Causal AI for Learning ‘Digital Twins’ from Human Multi-Omic Data for Drug […]
Meet us at Bio-IT World Conference in Boston
We are thrilled to announce that Joe Donahue will be chairing a session entitled “Discover Novel Drug Candidates to Produce Better Precision Medicines” at the Bio-IT World Conference on May 18th at 10:20 ET, as part of the “AI for Drug Discovery and Development” track. The AI for Drug Discovery and Development track is an […]
Join Aitia at Charles River’s sixth Annual World Congress
We are excited to announce that Colin Hill will be speaking at Charles River’s sixth Annual World Congress on May 11, 2023, in Cambridge, MA. Colin’s session will focus on “Al and Digital Twins to Drive the Next Generation of Drug Discovery and Development”. The presentation will be followed by a fireside chat with Julie […]
Join Aitia and our Partner GAP at the American Academy of Neurology Annual Meeting 2023
We are excited to announce our attendance at the American Academy of Neurology Annual Meeting 2023, which will be held in Boston. As we look forward to this event, we are also pleased to be joined by our strategic partner the Global Alzheimer’s Platform Foundation (GAP). Together, we are committed to advancing the field of […]